Foscarnet Drug Interactions
Currently displaying 247 drugs known to have a moderate interaction with foscarnet.
Moderate interactions with foscarnet
Note: Showing generic names only.
A
- abarelix
- abiraterone
- adenosine
- albuterol
- alendronate
- alfuzosin
- amifampridine
- amifostine
- amitriptyline
- amoxapine
- apalutamide
- apomorphine
- arformoterol
- aripiprazole
- asciminib
- asenapine
- astemizole
- atomoxetine
- azithromycin
B
- balsalazide
- betamethasone
- bicalutamide
- bisacodyl
- bitolterol
- bosutinib
- budesonide
- bumetanide
- buprenorphine
C
- calcitonin
- casanthranol
- cascara sagrada
- castor oil
- cellulose sodium phosphate
- chlorpromazine
- cilostazol
- cinoxacin
- ciprofloxacin
- cisplatin
- clarithromycin
- clofarabine
- clofazimine
- clomipramine
- corticorelin
- corticotropin
- cortisone
- cosyntropin
D
- darolutamide
- dasatinib
- daunorubicin
- daunorubicin liposomal
- deflazacort
- degarelix
- delafloxacin
- denosumab
- desipramine
- deutetrabenazine
- dexamethasone
- dexlansoprazole
- dimethyl fumarate
- diroximel fumarate
- donepezil
- doxepin
- doxorubicin
- doxorubicin liposomal
E
- encorafenib
- enoxacin
- entecavir
- entrectinib
- enzalutamide
- epirubicin
- eribulin
- erythromycin
- esomeprazole
- ethacrynic acid
- etidronate
- exenatide
- ezogabine
F
- famotidine
- flecainide
- fluconazole
- flucytosine
- fludrocortisone
- fluoxetine
- fluphenazine
- flutamide
- formoterol
- fostemsavir
- furosemide
G
- galantamine
- gallium nitrate
- gatifloxacin
- gemifloxacin
- gepirone
- gilteritinib
- ginkgo
- givinostat
- glasdegib
- glycerin
- goserelin
- granisetron
- grepafloxacin
H
I
K
L
- lactitol
- lactulose
- lansoprazole
- lapatinib
- lenvatinib
- leuprolide
- levalbuterol
- levofloxacin
- licorice
- lindane topical
- lisdexamfetamine
- lithium
- lofexidine
- lomefloxacin
- loperamide
M
- macimorelin
- magnesium citrate
- magnesium hydroxide
- maprotiline
- mavorixafor
- mefloquine
- mesalamine
- metaproterenol
- methotrimeprazine
- methoxyflurane
- methylprednisolone
- metronidazole
- midostaurin
- mineral oil
- mirtazapine
- monomethyl fumarate
- moxifloxacin
N
O
- ofloxacin
- olanzapine
- oliceridine
- olodaterol
- olsalazine
- omeprazole
- ondansetron
- osilodrostat
- oxaliplatin
- oxidronate
- oxytocin
P
- paliperidone
- palonosetron
- pamidronate
- pantoprazole
- pazopanib
- pemetrexed
- perflutren
- perphenazine
- phenolphthalein
- pimavanserin
- pirbuterol
- pitolisant
- plicamycin
- polyethylene glycol 3350
- polyethylene glycol 3350 with electrolytes
- posaconazole
- potassium acid phosphate
- potassium phosphate
- pralsetinib
- prednisolone
- prednisone
- primaquine
- probucol
- prochlorperazine
- promazine
- promethazine
- propafenone
- propofol
- propoxyphene
- protriptyline
Q
R
- rabeprazole
- ranolazine
- relugolix
- remdesivir
- rilpivirine
- risedronate
- risperidone
- ritodrine
- rivastigmine
- romidepsin
- romosozumab
- rucaparib
S
- salmeterol
- samarium sm 153 lexidronam
- senna
- sertraline
- sevoflurane
- sodium phosphate
- solifenacin
- sorafenib
- sparfloxacin
- sulfasalazine
- sunitinib
T
- tacrine
- tamoxifen
- tebentafusp
- telavancin
- telbivudine
- telithromycin
- terbutaline
- terfenadine
- tetrabenazine
- thalidomide
- tiludronate
- tizanidine
- torsemide
- trazodone
- triamcinolone
- triclabendazole
- trifluoperazine
- triflupromazine
- trimeprazine
- trimipramine
- triptorelin
- trovafloxacin
V
Z
Foscarnet disease interactions
There are 4 disease interactions with foscarnet which include:
More about foscarnet
- foscarnet consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antivirals
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.